                               SEQUENCE LISTING

<110> IMMUNOMEDICS, INC.
 
<120> T20 CONSTRUCTS FOR ANTI-HIV (HUMAN IMMUNODEFICIENCY VIRUS) 
      THERAPY AND/OR VACCINES

<130> IMM360WO1

<140>
<141>

<150> 62/167,404
<151> 2015-05-28

<160> 16    

<170> PatentIn version 3.5

<210> 1
<211> 5132
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 1
acattaccct gttatcccta gatgacatta ccctgttatc ccagatgaca ttaccctgtt       60

atccctagat gacattaccc tgttatccct agatgacatt taccctgtta tccctagatg      120

acattaccct gttatcccag atgacattac cctgttatcc ctagatacat taccctgtta      180

tcccagatga cataccctgt tatccctaga tgacattacc ctgttatccc agatgacatt      240

accctgttat ccctagatac attaccctgt tatcccagat gacataccct gttatcccta      300

gatgacatta ccctgttatc ccagatgaca ttaccctgtt atccctagat acattaccct      360

gttatcccag atgacatacc ctgttatccc tagatgacat taccctgtta tcccagatga      420

cattaccctg ttatccctag atacattacc ctgttatccc agatgacata ccctgttatc      480

cctagatgac attaccctgt tatcccagat gacattaccc tgttatccct agatacatta      540

ccctgttatc ccagatgaca taccctgtta tccctagatg acattaccct gttatcccag      600

atgacattac cctgttatcc ctagatacat taccctgtta tcccagatga cataccctgt      660

tatccctaga tgacattacc ctgttatccc agataaactc aatgatgatg atgatgatgg      720

tcgagactca gcggccgcgg tgccagggcg tgcccttggg ctccccgggc gcgactagtg      780

aattcagatc tgatatctct agaggcccat tgcatacgtt gtatccatat cataatatgt      840

acatttatat tggctcatgt ccaacattac cgccatgttg acattgatta ttgactagtt      900

attaatagta atcaattacg gggtcattag ttcatagccc atatatggag ttccgcgtta      960

cataacttac ggtaaatggc ccgcctggct gaccgcccaa cgacccccgc ccattgacgt     1020

caataatgac gtatgttccc atagtaacgc caatagggac tttccattga cgtcaatggg     1080

tggagtattt acggtaaact gcccacttgg cagtacatca agtgtatcat atgccaagta     1140

cgccccctat tgacgtcaat gacggtaaat ggcccgcctg gcattatgcc cagtacatga     1200

ccttatggga ctttcctact tggcagtaca tctacgtatt agtcatcgct attaccatgg     1260

tgatgcggtt ttggcagtac atcaatgggc gtggatagcg gtttgactca cggggatttc     1320

caagtctcca ccccattgac gtcaatggga gtttgttttg gcaccaaaat caacgggact     1380

ttccaaaatg tcgtaacaac tccgccccat tgacgcaaat gggcggtagg cgtgtacggt     1440

gggaggtcta tataagcaga gctcgtttag tgaaccgtca gatcgcctgg agacgccatc     1500

cacgctgttt tgacctccat agaagacacc gggaccgatc cagcctccgc ggcccgcgca     1560

cggcaagagg cgaggggcgg cgactgaatt gggtgtcgac cagccaccat ggagacagac     1620

acactcctgc tatgggtact gctgctctgg gttccaggtt ccactggtga cgcggcctat     1680

accagcctga ttcatagcct gattgaagaa agccagaacc agcaggaaaa aaacgaacag     1740

gaactgctgg aactggataa atgggcgagc ctgtggaact ggttttgaga attcatcgag     1800

taactattgt gtcatgcaac ataaataaac ttattgtttc aacacctact aattgtgctg     1860

caggggcccg ccccaactgg ggtaaccttt gagttctctc agttgggggt aatcagcatc     1920

atgatgtggt accacatcat gatgctgatt ataagaatgc ggccgccaca ctctagtgga     1980

tctcgagtta ataattcaga agaactcgtc aagaaggcga tagaaggcga tgcgctgcga     2040

atcgggagcg gcgataccgt aaagcacgag gaagcggtca gcccattcgc cgccaagctc     2100

ttcagcaata tcacgggtag ccaacgctat gtcctgatag cggtccgcca cacccagccg     2160

gccacagtcg atgaatccag aaaagcggcc attttccacc atgatattcg gcaagcaggc     2220

atcgccatgg gtcacgacga gatcctcgcc gtcgggcatg ctcgccttga gcctggcgaa     2280

cagttcggct ggcgcgagcc cctgatgctc ttcgtccaga tcatcctgat cgacaagacc     2340

ggcttccatc cgagtacgtg ctcgctcgat gcgatgtttc gcttggtggt cgaatgggca     2400

ggtagccgga tcaagcgtat gcagccgccg cattgcatca gccatgatgg atactttctc     2460

ggcaggagca aggtgtagat gacatggaga tcctgccccg gcacttcgcc caatagcagc     2520

cagtcccttc ccgcttcagt gacaacgtcg agcacagctg cgcaaggaac gcccgtcgtg     2580

gccagccacg atagccgcgc tgcctcgtct tgcagttcat tcagggcacc ggacaggtcg     2640

gtcttgacaa aaagaaccgg gcgcccctgc gctgacagcc ggaacacggc ggcatcagag     2700

cagccgattg tctgttgtgc ccagtcatag ccgaatagcc tctccaccca agcggccgga     2760

gaacctgcgt gcaatccatc ttgttcaatc atgcgaaacg atcctcatcc tgtctcttga     2820

tcagagcttg atcccctgcg ccatcagatc cttggcggcg agaaagccat ccagtttact     2880

ttgcagggct tcccaacctt accagagggc gccccagctg gcaattccgg ttcgcttgct     2940

gtccataaaa ccgcccagtc tagctatcgc catgtaagcc cactgcaagc tacctgcttt     3000

ctctttgcgc ttgcgttttc ccttgtccag atagcccagt agctgacatt catccggggt     3060

cagcaccgtt tctgcggact ggctttctac gtgctcgagg ggggccaaac ggtctccagc     3120

ttggctgttt tggcggatga gagaagattt tcagcctgat acagattaaa tcagaacgca     3180

gaagcggtct gataaaacag aatttgcctg gcggcagtag cgcggtggtc ccacctgacc     3240

ccatgccgaa ctcagaagtg aaacgccgta gcgccgatgg tagtgtgggg tctccccatg     3300

cgagagtagg gaactgccag gcatcaaata aaacgaaagg ctcagtcgaa agactgggcc     3360

tttcgtttta tctgttgttt gtcggtgaac gctctcctga gtaggacaaa tccgccggga     3420

gcggatttga acgttgcgaa gcaacggccc ggagggtggc gggcaggacg cccgccataa     3480

actgccaggc atcaaattaa gcagaaggcc atcctgacgg atggcctttt tgcgtttcta     3540

caaactcttt tgtttatttt tctaaataca ttcaaatatg tatccgctca tgaccaaaat     3600

cccttaacgt gagttttcgt tccactgagc gtcagacccc gtagaaaaga tcaaaggatc     3660

ttcttgagat cctttttttc tgcgcgtaat ctgctgcttg caaacaaaaa aaccaccgct     3720

accagcggtg gtttgtttgc cggatcaaga gctaccaact ctttttccga aggtaactgg     3780

cttcagcaga gcgcagatac caaatactgt ccttctagtg tagccgtagt taggccacca     3840

cttcaagaac tctgtagcac cgcctacata cctcgctctg ctaatcctgt taccagtggc     3900

tgctgccagt ggcgataagt cgtgtcttac cgggttggac tcaagacgat agttaccgga     3960

taaggcgcag cggtcgggct gaacgggggg ttcgtgcaca cagcccagct tggagcgaac     4020

gacctacacc gaactgagat acctacagcg tgagctatga gaaagcgcca cgcttcccga     4080

agggagaaag gcggacaggt atccggtaag cggcagggtc ggaacaggag agcgcacgag     4140

ggagcttcca gggggaaacg cctggtatct ttatagtcct gtcgggtttc gccacctctg     4200

acttgagcgt cgatttttgt gatgctcgtc aggggggcgg agcctatgga aaaacgccag     4260

caacgcggcc tttttacggt tcctggcctt ttgctggcct tttgctcaca tgttctttcc     4320

tgcgttatcc cctgattctg tggataaccg tattaccgcc tttgagtgag ctgataccgc     4380

tcgccgcagc cgaacgaccg agcgcagcga gtcagtgagc gaggaagcgg aagagcgcct     4440

gatgcggtat tttctcctta cgcatctgtg cggtatttca caccgcatat ggtgcactct     4500

cagtacaatc tgctctgatg ccgcatagtt aagccagtat acactccgct atcgctacgt     4560

gactgggtca tggctgcgcc ccgacacccg ccaacacccg ctgacgcgcc ctgacgggct     4620

tgtctgctcc cggcatccgc ttacagacaa gctgtgaccg tctccgggag ctgcatgtgt     4680

cagaggtttt caccgtcatc accgaaacgc gcgaggcagc agatcaattc gcgcgcgaag     4740

gcgaagcggc atgcataatg tgcctgtcaa atggacgaag cagggattct gcaaacccta     4800

tgctactccg tcaagccgtc aattgtctga ttcgttacca attatgacaa cttgacggct     4860

acatcattca ctttttcttc acaaccggca cggaactcgc tcgggctggc cccggtgcat     4920

tttttaaata cccgcgagaa atagagttga tcgtcaaaac caacattgcg accgacggtg     4980

gcgataggca tccgggtggt gctcaaaagc agcttcgcct ggctgatacg ttggtcctcg     5040

cgccagctta agacgctaat ccctaactgc tggcggaaaa gatgtgacag acgcgacggc     5100

gacaagcaaa catgctgtgc gacgctggcg at                                   5132


<210> 2
<211> 36
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 2
Tyr Thr Ser Leu Ile His Ser Leu Ile Glu Glu Ser Gln Asn Gln Gln 
1               5                   10                  15      


Glu Lys Asn Glu Gln Glu Leu Leu Glu Leu Asp Lys Trp Ala Ser Leu 
            20                  25                  30          


Trp Asn Trp Phe 
        35      


<210> 3
<211> 472
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polynucleotide

<400> 3
ggcggccaca tccagatccc gccggggctc acggagctgc tgcagggcta cacggtggag       60

gtgctgcgac agcagccgcc tgacctcgtc gaattcgcag tggagtactt cacccgcctg      120

agagaagctc gcgctgagtt ccctaaaccc agcactccac ccggatcttc cggccaccac      180

caccaccacc acggatccta taccagcctg attcatagcc tgattgaaga aagccagaac      240

cagcaggaaa aaaacgaaca ggaactgctg gaactggata aatgggcgag cctgtggaac      300

tggttttgac tcgagcacca ccaccaccac cactgagatc cggctgctaa caaagcccga      360

aaggaagctg agttggctgc tgccaccgct gagcaataac tagcataacc ccttggggcc      420

tctaaacggg tcttgagggg ttttttgctg aaaggaggaa ctatatccgg at              472


<210> 4
<211> 44
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 4
Ser His Ile Gln Ile Pro Pro Gly Leu Thr Glu Leu Leu Gln Gly Tyr 
1               5                   10                  15      


Thr Val Glu Val Leu Arg Gln Gln Pro Pro Asp Leu Val Glu Phe Ala 
            20                  25                  30          


Val Glu Tyr Phe Thr Arg Leu Arg Glu Ala Arg Ala 
        35                  40                  


<210> 5
<211> 45
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 5
Cys Gly His Ile Gln Ile Pro Pro Gly Leu Thr Glu Leu Leu Gln Gly 
1               5                   10                  15      


Tyr Thr Val Glu Val Leu Arg Gln Gln Pro Pro Asp Leu Val Glu Phe 
            20                  25                  30          


Ala Val Glu Tyr Phe Thr Arg Leu Arg Glu Ala Arg Ala 
        35                  40                  45  


<210> 6
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Gln Ile Glu Tyr Leu Ala Lys Gln Ile Val Asp Asn Ala Ile Gln Gln 
1               5                   10                  15      


Ala 
    


<210> 7
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Cys Gly Gln Ile Glu Tyr Leu Ala Lys Gln Ile Val Asp Asn Ala Ile 
1               5                   10                  15      


Gln Gln Ala Gly Cys 
            20      


<210> 8
<211> 50
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 8
Ser Leu Arg Glu Cys Glu Leu Tyr Val Gln Lys His Asn Ile Gln Ala 
1               5                   10                  15      


Leu Leu Lys Asp Ser Ile Val Gln Leu Cys Thr Ala Arg Pro Glu Arg 
            20                  25                  30          


Pro Met Ala Phe Leu Arg Glu Tyr Phe Glu Arg Leu Glu Lys Glu Glu 
        35                  40                  45              


Ala Lys 
    50  


<210> 9
<211> 55
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 9
Met Ser Cys Gly Gly Ser Leu Arg Glu Cys Glu Leu Tyr Val Gln Lys 
1               5                   10                  15      


His Asn Ile Gln Ala Leu Leu Lys Asp Ser Ile Val Gln Leu Cys Thr 
            20                  25                  30          


Ala Arg Pro Glu Arg Pro Met Ala Phe Leu Arg Glu Tyr Phe Glu Arg 
        35                  40                  45              


Leu Glu Lys Glu Glu Ala Lys 
    50                  55  


<210> 10
<211> 23
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Cys Gly Phe Glu Glu Leu Ala Trp Lys Ile Ala Lys Met Ile Trp Ser 
1               5                   10                  15      


Asp Val Phe Gln Gln Gly Cys 
            20              


<210> 11
<211> 51
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 11
Ser Leu Arg Glu Cys Glu Leu Tyr Val Gln Lys His Asn Ile Gln Ala 
1               5                   10                  15      


Leu Leu Lys Asp Val Ser Ile Val Gln Leu Cys Thr Ala Arg Pro Glu 
            20                  25                  30          


Arg Pro Met Ala Phe Leu Arg Glu Tyr Phe Glu Lys Leu Glu Lys Glu 
        35                  40                  45              


Glu Ala Lys 
    50      


<210> 12
<211> 54
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 12
Ser Leu Lys Gly Cys Glu Leu Tyr Val Gln Leu His Gly Ile Gln Gln 
1               5                   10                  15      


Val Leu Lys Asp Cys Ile Val His Leu Cys Ile Ser Lys Pro Glu Arg 
            20                  25                  30          


Pro Met Lys Phe Leu Arg Glu His Phe Glu Lys Leu Glu Lys Glu Glu 
        35                  40                  45              


Asn Arg Gln Ile Leu Ala 
    50                  


<210> 13
<211> 44
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 13
Ser His Ile Gln Ile Pro Pro Gly Leu Thr Glu Leu Leu Gln Gly Tyr 
1               5                   10                  15      


Thr Val Glu Val Gly Gln Gln Pro Pro Asp Leu Val Asp Phe Ala Val 
            20                  25                  30          


Glu Tyr Phe Thr Arg Leu Arg Glu Ala Arg Arg Gln 
        35                  40                  


<210> 14
<211> 44
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 14
Ser Ile Glu Ile Pro Ala Gly Leu Thr Glu Leu Leu Gln Gly Phe Thr 
1               5                   10                  15      


Val Glu Val Leu Arg His Gln Pro Ala Asp Leu Leu Glu Phe Ala Leu 
            20                  25                  30          


Gln His Phe Thr Arg Leu Gln Gln Glu Asn Glu Arg 
        35                  40                  


<210> 15
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 15
gagttcccta aacccagcac tccacccgga tcttccggc                              39


<210> 16
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
His His His His His His Gly Ser 
1               5               


